Lymph-node ratio is an important clinical determinant for selecting the appropriate adjuvant chemotherapy regimen for curative D2-resected gastric cancer
Jun‐Eul Hwang(Chonnam National University Hwasun Hospital), Ik‐Joo Chung(Chonnam National University Hwasun Hospital), Seong Yeob Ryu(Chonnam National University), Eu Chang Hwang(Chonnam National University Hwasun Hospital), Oh Jeong(Chonnam National University), Sang‐Hee Cho(Chonnam National University), Hyun‐Jeong Shim(Chonnam National University Hwasun Hospital), Young Kyu Park(Chonnam National University Hwasun Hospital), Woo‐Kyun Bae(Chonnam National University Hwasun Hospital), Hyeon-Jong Kim(Chonnam National University Hwasun Hospital)
Cited by 23
Related Papers
Discovery of common and rare genetic risk variants for colorectal cancer
|Nature Genetics|2018|613
Effect of Laparoscopic Distal Gastrectomy vs Open Distal Gastrectomy on Long-term Survival Among Patients With Stage I Gastric Cancer
|JAMA Oncology|2019|508
Transcriptional recapitulation and subversion of embryonic colon development by mouse colon tumor models and human colon cancer
|Genome biology|2007|343
Neoadjuvant and adjuvant pembrolizumab plus chemotherapy in locally advanced gastric or gastro-oesophageal cancer (KEYNOTE-585): an interim analysis of the multicentre, double-blind, randomised phase 3 study
|The Lancet Oncology|2023|336
Long-Term Results of Laparoscopic Gastrectomy for Gastric Cancer: A Large-Scale Case-Control and Case-Matched Korean Multicenter Study
|Journal of Clinical Oncology|2014|326